SLC7A11 and neoplasm: Furthermore, immunotherapy sensitizes tumors to radiotherapy by promoting tumor-cell ferroptosis through IFNγ-induced SLC7A11 suppression, suggesting that ferroptosis may serve as a determinant of synergy between radiotherapy and immunotherapy (Lang et al., 2019).